Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Dexcom (DXCM) Inventory Average (2016 - 2026)

Dexcom has reported Inventory Average over the past 16 years, most recently at $661.4 million for Q1 2026.

  • Quarterly Inventory Average rose 22.38% to $661.4 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $661.4 million through Mar 2026, up 22.38% year-over-year, with the annual reading at $585.8 million for FY2025, 6.31% up from the prior year.
  • Inventory Average was $661.4 million for Q1 2026 at Dexcom, up from $616.6 million in the prior quarter.
  • Over five years, Inventory Average peaked at $661.4 million in Q1 2026 and troughed at $308.8 million in Q4 2022.
  • The 5-year median for Inventory Average is $540.4 million (2025), against an average of $488.3 million.
  • Year-over-year, Inventory Average dropped 12.83% in 2022 and then surged 71.31% in 2023.
  • A 5-year view of Inventory Average shows it stood at $308.8 million in 2022, then surged by 71.31% to $529.1 million in 2023, then increased by 6.68% to $564.4 million in 2024, then rose by 9.24% to $616.6 million in 2025, then increased by 7.26% to $661.4 million in 2026.
  • Per Business Quant, the three most recent readings for DXCM's Inventory Average are $661.4 million (Q1 2026), $616.6 million (Q4 2025), and $587.4 million (Q3 2025).